Success Stories: A Week Was All It Took for the USCIS to Approve the EB-1A Petition of a Neuropharmacology Expert from China (130 Citations)
Client’s Testimonial:
“I appreciate the professional suggestions and help through the process.”
On May 27th, 2017, we received another EB-1A (Alien of Extraordinary Ability) approval for a Petitioner in the Field of Neuropharmacology (Approval Notice).
General Field: Neuropharmacology
Position at the Time of Case Filing: N/A
Country of Origin: China
State of Residence at the Time of Filing: Ohio
Approval Notice Date: May 27th, 2017
Processing Time: 7 days (Premium Processing Requested)
Case Summary:
With 7 peer-reviewed scientific articles and 2 peer-reviewed abstracts in her name as well as years of experience working in the field of neuropharmacology, our client seemed like a good candidate for EB-1A (Alien of Extraordinary Ability). After we evaluated her credentials and confirmed that we could build a solid case on her behalf, we got to work gathering a wealth of information pertaining to her achievements in the field.
For one, we used Google Scholar to determine our client’s citation count at the time of filing. The 130 citations her work had collected served as ample proof that her findings are helping other researchers to progress their work. Furthermore, we confirmed that our client had conducted 17 peer reviews for a variety of high-impact scientific journals. As only the cream of the crop are invited to judge the work of their peers, our client’s peer review record proved to the USCIS that her ideas and opinions are highly respected by members of the international scientific community.
To further strengthen our client’s EB1A case, we encouraged her to obtain recommendation letters from her peers. Our client persuaded six neuropharmacology experts to advocate for the approval of her EB1A petition, one of whom stated that our client’s work “... is of great benefit to the field of neuropharmacology research and, consequently, the treatment of neurodegenerative eye diseases.” Another expert echoed his sentiments by stating that “Considering the significant value of these findings for developing new insomnia medications with fewer side effects, it is undeniable that [Client’s] ongoing work in this area is of profound value to the millions of U.S. citizens living with insomnia.”
As our client elected to file her EB-1A petition using Premium Processing (PP), she received notification of case approval merely one week after filing. We join her as she celebrates this victory, and everyone at North America Immigration Law Group (WeGreneed.com) wishes her and her husband the best as they adjust their status for permanent residence.